Authors


Dr Dan Z. Reinstein

Latest:

Non-linear aspheric corneal ablation can be used to treat presbyopia

Presbyopia can be treated in emmetropic, myopic and hyperopic patients with refractive errors between +5.75 and -9.00 D using corneal non-linear aspheric ablation profiles to increase the depth of field in both eyes, in combination with micro-monovision. Patient satisfaction with this approach is high.


Dr Sheetal Brar, MS

Latest:

Myth or reality? Corneal refractive surgery to manage presbyopic patients

A corneal refractive technique can combine monovision and extended depth of field to create a wide, seamless range of functional vision. This can provide independence from spectacles.


Caroline Catt, MB, BS, FRANZCO

Latest:

Crafting an international database for retinopathy of prematurity

Intercontinental collaboration is key to unlocking ROP in our lifetime


Shigeru Kinoshita, MD, PhD; and Edward J. Holland, MD

Latest:

Innovation and the clinician scientist

Collaboration and outside-the-box thinking present significant opportunities for science and industry


Bonnie An Henderson, MD

Latest:

AAO 2024: Advancing medical education with AI, robotics, and diverse learning methods

In her Kelman Lecture presentation, Bonnie An Henderson, MD, highlights the importance of continuous education for clinicians.


Lisa Stewart, PhD

Latest:

The pathophysiology and pathomorphology of corneal ectasia: Part 4

Corneal cross-linking (CXL) is improving all the time, although all protocols retain the basic requirements for oxygen, riboflavin and UV light. Recent developments mean that CXL at the slit lamp is feasible, which will improve access to the procedure.


Prof. Boris Malyugin

Latest:

Simplifying cataract surgery in patients with poor mydriasis, compromised zonules

The Malyugin Ring 2.0 simplifies challenging cases of small pupils with zonulopathy by both stabilising the capsular bag and dilating the pupil.


Dr Maximilian J. Gerhardt

Latest:

First-ever retinal gene therapy: Does real-world experience back its use?

Recent reports of retinal atrophy have raised concerns on potential long-term safety.


By Artemis Matsou, MD, MRCP(UK), FEBOS-CR, FEBO, PgDip CRS; and Richard Packard, MD, FRCS, FRCOphth

Latest:

On the 75th anniversary of the IOL, modern surgeons pay tribute

At the ESCRS meeting, Sir Harold Ridley’s legacy was put on display in a pop-up museum installation


Prof. Vincent Daien

Latest:

Assessing the quality of real-world evidence in retinal diseases

A recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.


Dr Roberto Pinelli

Latest:

New approach to foveal holes: Light, sound and nutraceuticals

Novel treatment results in macular hole closure.


Dr Ciara O'Byrne
Dr Ciara O'Byrne

Latest:

Code-free deep learning: The next phase of AI-enabled healthcare?

Code-free deep learning models are expected to find applications across a range of areas to improve patient care, increase accessibility to healthcare, accelerate clinical research and enhance medical education.


Lynda Charters; Reviewed by Dr Neeru Gupta

Latest:

Straightforward procedures for leaking blebs: No incision required

Surgeons can consider a relatively simple, inexpensive, efficient and accessible incision-free procedure to preserve blebs.


Miss Sally Justus; Reviewed by Dr Ruth Hamilton

Latest:

The increasing potential of electroretinography in ophthalmic diagnostics

Recent improvements in electroretinography are making the technique more accessible for general use. It has a wide range of clinical applications.


Dr Antoine Roure
Dr Antoine Roure

Latest:

Experiencing the PresbyLASIK procedure as both surgeon and patient

Laser vision advancements have made safe, reliable and stable procedures a reality.


Patrick Yu-Wai-Man, BMedSci, MBBS, PhD, FRCPath, FRCOphth

Latest:

The ins and outs of gene therapy for inherited optic neuropathies

A look at what’s in the therapeutic delivery pipeline for these disorders.


Luis Fernández-Vega Cueto-Felgueroso, MD, PhD

Latest:

Onboarding a new trifocal hydrophobic C-loop IOL My early experiences with AT ELANA® 841P from ZEISS

Diabetic Retinopathy ranked as the fifth most common cause of blindness among adults aged 50 and older in 2020 according to data from the Global Burden of Disease study. Aude Couturier, MD shares her experience of using advanced imaging technologies to optimize diagnosis and surgical management of her DR patients in our latest Case of the Month.


By Lynda Charters; Reviewed by Alexandra Miere, MD, PhD

Latest:

Hemorrhagic unilateral retinopathy: No proven aetiology for rare condition

Multimodal imaging and a systemic work-up failed to identify any underlying disorder for the hemorrhages



Prof. Pearse A. Keane
Prof. Pearse A. Keane

Latest:

Code-free deep learning: The next phase of AI-enabled healthcare?

Code-free deep learning models are expected to find applications across a range of areas to improve patient care, increase accessibility to healthcare, accelerate clinical research and enhance medical education.


Dr Doina Gherghel

Latest:

Tried and tested therapeutic options for meibomian gland dysfunction

Methods using a combination of non-invasive thermal treatments and meibomian gland expression seem to be particularly effective.


Dr Antonino Cuttitta

Latest:

Examining the stability of a new aspheric IOL in cataract patients

A new monofocal IOL was found to provide stability in the capsular bag 1 week and 1 month after implantation, with good refractive outcomes.


By Lynda Charters; Reviewed by Leon Marković, MD, PhD

Latest:

Untangling the genetic secrets of retinoblastoma

Identifying all genetic culprits may improve diagnostics and prognoses


Cheryl Guttman Krader; Reviewed by Dr Andric C. Perez-Ortiz

Latest:

Investigators explore pathogenic cytokines as biomarkers for DMO

Results of a study analysing cytokine levels in the aqueous humour and serum of patients with nonproliferative diabetic retinopathy with and without diabetic macular oedema support further research investigating transforming growth factor-β-induced Gene Human Clone 30 (BIGH3) as a potential biomarker for DMO.



By Lynda Charters; Reviewed by Damon Wong, PhD

Latest:

Machine learning: A view from new angles

More testing is needed to ensure accuracy across different groups


Richard Gale, PhD, MEd, BSc, MBChB, FRCP, FRCOphth

Latest:

Impact of Durable Therapies on Patients and Clinics and Monitoring Strategies

Panelists discuss how longer-acting treatments will enable extended intervals between visits while requiring careful adjustment of monitoring protocols and clinic workflows to balance reduced treatment burden with maintaining adequate disease surveillance.


By Lynda Charters; Reviewed by Sean Ianchulev, MD, and Ernest P. Chen, MD

Latest:

In-home Accustat vision test: Equivalent results to in-office Snellen measurements

Investigators emphasised a significant unmet need for home-based monitoring of visual function with patient-centric technologies



© 2025 MJH Life Sciences

All rights reserved.